Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CLPBY | MLI |
|---|---|---|
| Price | $6.24 | $62.97 |
| Change today | ▲ 0.81% | ▲ 0.66% |
| Market cap | $13.93B | $13.93B |
| Return, 3 months | +0.2% | +13.4% |
| Return, year to date | -25.7% | +10.6% |
| Return, 1 year | -29.5% | +27.7% |
| P/E (TTM) | 32.8 | 16.4 |
| P/B | 7.0 | 3.9 |
| P/E percentile vs own 5y | – | 81st |
| Dividend yield | 5.82% | 0.95% |
| Revenue growth (YoY, latest qtr) | – | +25.5% |
| Net profit growth (YoY) | – | +0.7% |
| Gross margin | – | 28.8% |
| Operating margin | – | 21.9% |
| Net margin | – | 18.2% |
| Return on equity | – | 26.3% |
| Analyst target vs. price | – | – |
| Analyst buy share | – | 100% |
| RSI (14) | 34 | 58 |
| 30-day volatility | 25.3% | 27.4% |
| Max drawdown, 1 year | -39.7% | -22.3% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
